DelistingOct 23, 2026, 05:16 PM
Medicus Pharma Regains Nasdaq Bid Price Compliance, Avoids Delisting
AI Summary
Medicus Pharma Ltd. announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00. The company had previously received a delisting determination letter after failing to meet the requirement by October 19, 2026, and was not eligible for an extension. However, the closing bid price has been at or above $1.00 for the past ten consecutive business days, leading Nasdaq to close the matter. The company cautioned that there is no assurance it will maintain future compliance.
Key Highlights
- Medicus Pharma Ltd. received notice from Nasdaq that it has regained compliance with the $1.00 minimum bid price requirement.
- The company had previously received a delisting determination letter as it failed to meet the minimum bid price by October 19, 2026.
- Nasdaq determined the company was not eligible for a second 180-day compliance period due to not meeting the minimum $5 million stockholders' equity requirement.
- The closing bid price of the Shares has been at $1.00 or greater for the last ten consecutive business days (October 12-23, 2026).
Price Impact
More from MDCX